Skip to main content
  • linkedin
  • Newsroom
  • Career
  • Contact
Hit enter to search or ESC to close
Close Search
Aboleris PharmaAboleris PharmaAboleris Pharma
search
Menu
  • About us
  • Our Science
  • Patient’s Center
  • Investors
  • search
All Posts By

Sven

AbolerIS Pharma Announces Publication in Molecular Therapy Cell Press Journal of New Preclinical Results Supporting Mechanism of Action of ABO21009, a First-in-Class Anti-CD45RC Antibody, Currently in Phase 1
News

AbolerIS Pharma Announces Publication in Molecular Therapy Cell Press Journal of New Preclinical Results Supporting Mechanism of Action of ABO21009, a First-in-Class Anti-CD45RC Antibody, Currently in Phase 1

Aboleris Pharma Appoints Seasoned Life-Sciences Executive Philippe Alen as Chief Business Officer
News

Aboleris Pharma Appoints Seasoned Life-Sciences Executive Philippe Alen as Chief Business Officer

AbolerIS Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases
News

AbolerIS Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases

GO Immuno Meeting 2023
Event

GO Immuno Meeting 2023

Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome
Publication

Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome

AIRE deficiency, from preclinical models to human APECED disease.
Publication

AIRE deficiency, from preclinical models to human APECED disease.

Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications
Publication

Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications

Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease
Publication

Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease

Human CD8+ Tregs expressing a MHC-specific chimeric antigen receptor display enhanced suppression of human skin rejection and GVHD in NSG mice
Publication

Human CD8+ Tregs expressing a MHC-specific chimeric antigen receptor display enhanced suppression of human skin rejection and GVHD in NSG mice

Immunophenotype of a rat model of Duchenne’s disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment
Publication

Immunophenotype of a rat model of Duchenne’s disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment

  • 1
  • 2
  • Next

© 2026 Aboleris Pharma. • Privacy • Cookie Policy • Terms and Conditions

Close Menu
  • About us
  • Our Science
  • Patient’s Center
  • Investors
  • Newsroom
  • Career
  • Contact
  • linkedin
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}